Lipid Metabolic Disorders and Liver Steatosis in DOCA-Salt Hypertensive Mice
Received Date: Nov 01, 2022 / Accepted Date: Nov 30, 2022 / Published Date: Nov 30, 2022
Abstract
Endogenous ligands for peroxisome proliferator-activated receptors include nitrooleic acid. The goal of the current investigation was to examine the therapeutic effects of OA-NO2 on lipid metabolism and hepatic steatosis in a mouse model of hypertension caused by deoxycorticosterone acetate salt. Male C57BL/6 mice were separated into two groups: one group got neither DOCA-salt nor OA-NO2, and the other received neither DOCA-salt nor OA-NO2 (control group). The hypertension was detected after a 3-week course of therapy with DOCA-salt + 1% sodium chloride in drinking water; however, OA-NO2 had no impact on the hypertension. Plasma triglyceride and total cholesterol levels in DOCA-salt-treated animals were considerably higher than those in control mice, but these parameters were markedly decreased after pretreatment with OA-NO2. Additionally, the histology of the liver showed increased lipid distribution along with more severe micro- and following DOCA-salt therapy, there was macro vesicular steatosis, which was consistent with the level of triglycerides and non-esterified fatty acids in the liver tissue.
Citation: Wang Y (2022) Lipid Metabolic Disorders and Liver Steatosis in DOCASalt Hypertensive Mice. J Diabetes Clin Prac 5: 169. Doi: 10.4172/jdce.1000169
Copyright: © 2022 Wang Y. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
黑料网 Journals
Article Tools
Article Usage
- Total views: 1709
- [From(publication date): 0-2022 - Nov 22, 2024]
- Breakdown by view type
- HTML page views: 1484
- PDF downloads: 225